Bio Therapeutics

Shares Pluristem Therapeutics Inc. (NASDAQ: PSTI), a biotherapeutics company that develops off-the-shelf allogeneic cell therapy products, surged higher by more than 16 percent on Thursday. Pluristem Therapeutics announced on Thursday that the U.S. Food and Drug Administration (FDA) granted the...